Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2821_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
1
Добавлен:
05.09.2026
Размер:
19 Мб
Скачать
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
moreappropriate,effective,andimmediatemanagementtobeinstituted.
ACKNOWLEDGMENTS
IwouldliketothankLorettaCacaceDPM,MPHforherexcellentassistanceinthepreparation of this manuscript for publication while a 4th-year student at the New York College of
PodiatricMedicine.
REFERENCES
FasanoA,BloemBR.Gaitdisorders.Continuum(MinneapMinn).2013;19(5):1344–1382.
D’AmicoJ.Developmentalflatfoot.In:ThompsonP,VolpeR,eds.Podopediatrics.Edinburgh,UK:ChurchillLivingstone;
2001:257–273.
StudenskiS,PereraS,PatelK,etal.Gaitspeedandsurvivalinolderadults.JAMA.2011;305(1):50–58.
Williams PT, ThompsonPD. Therelationshipof walkingintensity to totalandcause-specificmortality. results from the
nationalwalkers’healthstudy.PLoSOne.2013;8(11):e81098.
WrobelJS,NajafiB.Diabeticfootbiomechanicsandgaitdysfunction.JDiabetesSciTechnol.2010;4(4):833–845.
Bohannon RW, Williams Andrews A. Normal walking speed: A descriptive meta-analysis. Physiotherapy.
2011;97(3):182–189.
VachranukunkietT, Esquenazi A. Pathophysiology ofgait disturbance in neurologic disorders and clinicalpresentations.
PhysMedRehabilClinNAm.2013;24(2):233–246.
DietzV,DuysensJ.Significanceofloadreceptorinputduringlocomotion:Areview.GaitPosture.2000;11(2):102–110.
SalzmanB.Gaitandbalancedisordersinolderadults.AmFamPhysician.2010;82(1):61–68.
Spielberg PI. Walking patterns of old people: psychographic analysis. In: Bernstein NA, ed. Investigation on the
BiodynamicsofWalk ing,RunningandJumping:Part2.Moscow,Russia:CentralScientific;1940:72–76.
NapierJR.Theevolutionofbipedalwalkinginthehominids.ArchBiol(Liege).1964;75:673–708.
PerryJ,ed.ObservationalGaitAnalysis.Downey,CA:LosAmigosResearchandEducationInstitute;2001.
KirtleyC.ClinicalGaitAnalysis:TheoryandPractice.Amsterdam,Netherlands:ElsevierHealthSciences;2006.
IlgW,GollaH,ThierP,etal.Specificinfluencesofcerebellardysfunctionsongait.Brain.2007;130(Pt3):786–798.
MortonSM,BastianAJ.Cerebellarcontrolofbalanceandlocomotion.Neuroscientist.2004;10(3):247–259.
Stolze H, Klebe S, Petersen G, et al. Typical features of cerebellar ataxic gait. J Neurol Neurosurg Psychiatry.
2002;73(3):310–312.
HsuAL,TangPF,JanMH.Analysisofimpairmentsinfluencinggaitvelocityandasymmetryofhemiplegicpatientsafter
mildtomoderatestroke.ArchPhysMedRehabil.2003;84(8):1185–1193.
JenkersI,DelpS,PattenC.Capacitytoincreasewalkingspeedislimitedbyimpairedhipandanklepowergenerationin
lowerfunctioningpersonspost-stroke.GaitPosture.2009;29(1):129–137.
DenOtterAR,GeurtsAC,MulderT,etal.Abnormalitiesinthetemporalpatterningoflowerextremitymuscleactivityin
hemipareticgait.GaitPosture.2007;25(3):342–352.
Boonstra TA, vanVugt JP, van der Kooij H, et al. Balance asymmetry in Parkinson’s disease and its contribution to
freezingofgait.PLoSOne.2014;9(7):e102493.
Morris M, Iansek R, Smithson F, et al. Postural instability in Parkinson’s disease: a comparison with and without a
concurrenttask.GaitPosture.2000;12(3):205–216.
BennettDA,BeckettLA,MurrayAM,etal.Prevalence ofparkinsoniansignsandassociatedmortalityina community
populationofolderpeople.NEnglJMed.1996;334(2):71–76.
VergheseJ,LeValleyA,HallCB,etal.Epidemiologyofgaitdisordersincommunity-residingolderadults. JAmGeriatr
Soc.2006;54(2):255–261.
SaintS,WieseJ,BentS.ClinicalClerkships:TheAnswerBook .NewYork,NY:LippincottWilliams&Wilkins;2006.
Lee SM,KimM,LeeHM,etal.Differentialdiagnosis ofparkinsonismwith visualinspectionofposture andgaitinthe
earlystage.GaitPosture.2014;39(4):1138–1141.
HughesJR,Bowes SG,LeemanAL,etal.Parkinsonianabnormalityoffootstrike:aphenomenonofageingand/orone
responsivetolevodopatherapy?BrJClinPharmacol.1990;29(2):179–186.
MurrayMP,SepicSB,GardnerGM,etal.Walkingpatternsofmenwithparkinsonism.AmJ PhysMed.1978;57(6):278–
https://t.me/medicina_free
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
294.
KimmeskampS,HennigEM.Heeltotoemotioncharacteristics inParkinsonpatientsduringfreewalking.Clin Biomech
(Bristol,Avon).2001;16(9):806–812.
Koozekanani SH,Balmaseda MT Jr,Fatehi MT, etal. Groundreactionforces duringambulation inParkinsonism: pilot
study.ArchPhysMedRehabil.1987;68(1):28–30.
UenoE,Yanagisawa N,Takami M. Gait disordersinParkinsonism. Astudywith floorreaction forces and EMG.Adv
Neurol.1993;60:414–418.
Bloem BR, Hausdorff JM, Visser JE, et al. Falls and freezing of gait in Parkinson’s disease: a review of two
interconnected,episodicphenomena.MovDisord.2004;19(8):871–884.
Giladi N, Nieuwboer A. Understanding and treating freezing of gaitinparkinsonism, proposed working definition, and
settingthestage.MovDisord.2008;23(suppl2):S423–S425.
PlotnikM,GiladiN,BalashY,etal.IsfreezingofgaitinParkinson’sdiseaserelatedtoasymmetricmotorfunction?Ann
Neurol.2005;57(5):656–663.
PlotnikM,Giladi N, HausdorffJM. Bilateralcoordinationofwalkingandfreezing of gaitinParkinson’sdisease. Eur J
Neurosci.2008;27(8):1999–2006.
CioniM,RichardsCL,MalouinF,etal.Characteristicsoftheelectromyographicpatternsoflowerlimbmusclesduringgait
inpatientswithParkinson’sdiseasewhenOFFandONL-dopatreatment.ItalJNeurolSci.1997;18(4):195–208.
Robertson LT, Horak FB, Anderson VC, et al. Assessments of axial motor control during deep brain stimulation in
Parkinsonianpatients.Neurosurgery.2001;48(3):544–551;discussion551–552.
Davis JT, LyonsKE,Pahwa R. Freezingofgaitafter bilateralsubthalamic nucleus stimulation forParkinson’s disease.
ClinNeurolNeurosurg.2006;108(5):461–464.
CerebralPalsy
Botte MJ, Frank O. Chapter 3: Neuromuscular disorders. In: ThoradsenD, ed. Foot & Ank le (Orthopedic Surgery
Essentials).Philadelphia,PA:LippincottWilliams&Wilkins;2013:45–54.
RichardsLD,WhittleMW,eds.Whittle’sGaitAnalysis.NewYork,NY:ChurchillLivingston;2012.
HuisingaJM,SchmidKK,FilipiML,etal.Gaitmechanicsaredifferentbetweenhealthycontrolsandpatientswithmultiple
sclerosis.JApplBiomech.2013;29(3):303–311.
SocieMJ,MotlRW,PulaJH,etal.Gaitvariabilityanddisabilityinmultiplesclerosis.GaitPosture.2013;38(1):51–55.
NeptuneRR,KautzSA,ZajacFE.Contributionsoftheindividualankleplantarflexorstosupport,forwardprogressionand
swinginitiationduringwalking.JBiomech.2001;34(11):1387–1398.
Morris ME,CantwellC,VowelsL,etal.Changesin gait andfatigue from morningtoafternooninpeople withmultiple
sclerosis.JNeurolNeurosurgPsychiatry.2002;72(3):361–365.
CandrilliSD,DavisKL,KanHJ,etal.Prevalenceandtheassociatedburdenofillnessofsymptomsofdiabeticperipheral
neuropathyanddiabeticretinopathy.JDiabetesComplications.2007;21(5):306–314.
Chiles NS, Phillips CL, Volpato S, et al. Diabetes, peripheral neuropathy, and lower-extremity function. J Diabetes
Complications.2014;28(1):91–95.
DeshpandeAD,Harris-HayesM,SchootmanM.Epidemiologyofdiabetesanddiabetes-relatedcomplications.PhysTher.
2008;88(11):1254–1264.
FernandoM,CrowtherR,LazzariniP,etal.Biomechanicalcharacteristicsofperipheraldiabeticneuropathy:asystematic
review and meta-analysisof findingsfrom the gait cycle, muscle activity and dynamic barefoot plantar pressure. Clin
Biomech(Bristol,Avon).2013;28(8):831–845.
GreggEW,SorlieP,Paulose-RamR,etal.Prevalenceoflower-extremitydiseaseintheUSadultpopulation>=40yearsof
age with and without diabetes: 1999–2000 national health and nutrition examination survey. Diabetes Care.
2004;27(7):1591–1597.
GomesAA,OnoderaAN,OtuziME,etal.Electromyographyandkinematicchangesofgaitcycleatdifferentcadencesin
diabeticneuropathicindividuals.MuscleNerve.2011;44(2):258–268.
WrobelJS,NajafiB.Diabeticfootbiomechanicsandgaitdysfunction.JDiabetesSciTechnol.2010;4(4):833–845.
Sawacha Z,Spolaor F, GuarneriG, et al. Abnormal muscle activationduringgaitin diabetes patients with andwithout
neuropathy.GaitPosture.2012;35(1):101–105.
SaccoIC,AmadioAC.Influenceofthediabeticneuropathyonthebehaviorofelectromyographicandsensorialresponses
intreadmillgait.ClinBiomech(Bristol,Avon).2003;18(5):426–434.
BusSA,MaasM,CavanaghPR,etal.Plantarfat-paddisplacementinneuropathicdiabeticpatientswithtoedeformity:a
magneticresonanceimagingstudy.DiabetesCare.2004;27(10):2376–2381.
CheungYY,Doyley M, MillerTB, et al. Magnetic resonance elastographyof the plantar fatpads: preliminarystudy in
https://t.me/medicina_free
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
diabeticpatientsandasymptomaticvolunteers.JComputAssistTomogr.2006;30(2):321–326.
Tajaddini A, Scoffone HM, Botek G, et al. Laser-induced auto-fluorescence (LIAF) as a method for assessing skin
stiffnessprecedingdiabeticulcerformation.JBiomech.2007;40(4):736–741.
Thomas VJ, Patil KM,RadhakrishnanS,etal. The role of skin hardness,thickness,andsensory loss onstandingfoot
power inthe developmentof plantar ulcers in patients with diabetes mellitus—a preliminary study. Int J Low Extrem
Wounds.2003;2(3):132–139.
Yavuzer G, Yetkin I, Toruner FB, et al. Gait deviations of patients with diabetes mellitus: looking beyond peripheral
neuropathy.EuraMedicophys.2006;42(2):127–133.
GuiottoA,SawachaZ,GuarneriG,etal.Theroleoffootmorphologyonfootfunctionindiabeticsubjectswithorwithout
neuropathy.GaitPosture.2013;37(4):603–610.
CavanaghPR,SimoneauGG,UlbrechtJS.Ulceration,unsteadiness,anduncertainty:thebiomechanicalconsequencesof
diabetesmellitus.JBiomech.1993;26(suppl1):23–40.
CowleyMS,BoykoEJ,ShoferJB,etal.Footulcerriskandlocationinrelationtoprospectiveclinicalassessmentoffoot
shapeandmobilityamongpersonswithdiabetes.DiabetesResClinPract.2008;82(2):226–232.
LedouxWR,ShoferJB,SmithDG,etal.Relationshipbetweenfoottype,footdeformity,andulceroccurrenceinthehigh-
riskdiabeticfoot.JRehabilResDev.2005;42(5):665–672.
KiernanMC,VucicS,CheahBC,etal.Amyotrophiclateralsclerosis.Lancet.2011;377(9769):942–955.
Sharma KR, Kent-Braun JA, Majumdar S, et al. Physiology of fatigue in amyotrophic lateral sclerosis. Neurology.
1995;45(4):733–740.
WuY,Shi L. Analysisofalteredgaitcycle duration in amyotrophiclateralsclerosisbased onnonparametric probability
densityfunctionestimation.MedEngPhys.2011;33(3):347–355.
HausdorffJM,Lertratanakul A,Cudkowicz ME,et al. Dynamic markers of alteredgaitrhythmin amyotrophic lateral
sclerosis.JApplPhysiol(1985).2000;88(6):2045–2053.
ScafettaN,MarchiD,WestBJ.Understandingthecomplexityofhumangaitdynamics.Chaos.2009;19(2):026108.
WuY,NgSC.APDFclassificationofgaitcadencepatternsinpatientswithALS32ndAnnualInternationalConference
oftheIEEEEMBS;August31–September4,2010;BuenosAires,Argentina.
Sugavaneswaran L, Umapathy K, Krishnan S. Ambiguity domain-based identification of altered gait pattern in ALS
disorder.JNeuralEng.2012;9(4):046004-2560/9/4/046004.
Liao F, Wang J, He P. Multi-resolution entropy analysis of gait symmetry in neurological degenerative diseases and
amyotrophiclateralsclerosis.MedEngPhys.2008;30(3):299–310.
Eggermont LH, Gavett BE, Volkers KM, et al. Lower-extremity function in cognitively healthy aging, mild cognitive
impairment,andAlzheimer’sdisease.ArchPhysMedRehabil.2010;91(4):584–588.
GrasLZ,KanaanSF,McDowdJM,etal.Balance andgaitofadults withverymildAlzheimerdisease. JGeriatr Phys
Ther.2015;38(1):1–7.
Cedervall Y, Halvorsen K, Aberg AC. A longitudinal study of gait function and characteristics of gait disturbance in
individualswithAlzheimer’sdisease.GaitPosture.2014;39(4):1022–1027.
NadkarniNK,MawjiE,McIlroyWE,etal.SpatialandtemporalgaitparametersinAlzheimer’sdiseaseandaging.Gait
Posture.2009;30(4):452–454.
EnglishKL,Paddon-JonesD.Protectingmusclemassandfunctioninolderadultsduringbedrest.Curr Opin ClinNutr
MetabCare.2010;13(1):34–39.
BaanH,DubbeldamR,NeneAV,etal.Gaitanalysisofthelowerlimbinpatientswithrheumatoid arthritis:asystematic
review.SeminArthritisRheum.2012;41(6):768–788.e8.
TurnerDE,HelliwellPS,EmeryP,etal.Theimpactofrheumatoidarthritisonfootfunctionintheearlystagesofdisease:
aclinicalcaseseries.BMCMusculoskeletDisord.2006;7:102.
TurnerDE,Woodburn J,Helliwell PS, etal. Pes planovalgusin RA: adescriptive andanalyticalstudy of footfunction
determinedbygaitanalysis.MusculoskeletalCare.2003;1(1):21-33.
FuhrmannRA.Thetreatmentofrheumatoidfootdeformities.Orthopade.2002;31(12):1187–1197.
Giacomozzi C,Martelli F, Nagel A,et al. Cluster analysis to classify gait alterations in rheumatoid arthritisusing peak
pressurecurves.GaitPosture.2009;29(2):220–224.
TurnerDE,WoodburnJ. Characterisingtheclinicalandbiomechanicalfeaturesofseverelydeformedfeetinrheumatoid
arthritis.GaitPosture.2008;28(4):574–580.
RosenbaumD,SchmiegelA,MeermeierM,etal.Plantarsensitivity,footloadingandwalkingpaininrheumatoidarthritis.
Rheumatology(Oxford).2006;45(2):212–214.
TunaH,BirtaneM,TastekinN,etal.Pedobarographyanditsrelationtoradiologicerosionscoresinrheumatoidarthritis.
RheumatolInt.2005;26(1):42–47.
Woodburn J, Helliwell PS, Barker S. Three-dimensional kinematics at the ankle joint complex in rheumatoid arthritis
https://t.me/medicina_free
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
patientswithpainfulvalgusdeformityoftherearfoot.Rheumatology(Oxford).2002;41(12):1406–1412.
HennessyK,BurnsJ,PenkalaS. Reducingplantarpressureinrheumatoidarthritis:a comparisonofrunningversusoff-
the-shelforthopaedicfootwear.ClinBiomech(Bristol,Avon).2007;22(8):917–923.
CutoloM,SerioloB,CraviottoC,etal.CircadianrhythmsinRA.AnnRheumDis.2003;62(7):593–596.
GibbsJE,RayDW.Theroleofthecircadianclockinrheumatoidarthritis.ArthritisResTher.2013;15(1):205.
HelliwellP,Reay N,GilworthG, et al. Development of a foot impact scale forrheumatoidarthritis.Arthritis Rheum.
2005;53(3):418–422.
Backhouse MR, Pickles DA, Mathieson HR, et al. Diurnal variation of gait in patients with rheumatoid arthritis: the
DIVIGNstudy.ClinBiomech(Bristol,Avon).2014;29(7):811–814.
DubbeldamR,NeneAV,BuurkeJH,etal.Footandanklejointkinematicsinrheumatoidarthritiscannotonlybeexplained
byalterationinwalkingspeed.GaitPosture.2011;33(3):390–395.
Aletaha D, Smolen J, Ward MM. Measuring function in rheumatoid arthritis: identifying reversible and irreversible
components.ArthritisRheum.2006;54(9):2784–2792.
WeissRJ,WretenbergP,StarkA,etal.Gaitpatterninrheumatoidarthritis.GaitPosture.2008;28(2):229–234.
D’AmicoJC.Complexitiesofhalluxlimitusdictatetreatment.Biomechanics.2004;XI(4):51–91.
Kile T, Bouchard M. Degenerative joint disease of the ankle and hindfoot. In: Thoradsen D, ed. Foot & Ankle
(OrthopedicSurgeryEssentials).Philadelphia,PA:Lippincott,Williams&Wilkins;2013.
https://t.me/medicina_free
S
SECTIONA:
SoftTissueTumorsoftheFootandAnkle
oft tissue tumors of the foot and ankle are different from those of the rest of the
musculoskeletalsystemintermsoftype,riskofmalignancy,age,treatment,andprognosis. Tumors of the foot andankle maybedegenerative,reactive, posttraumatic, orneoplastic in origin,ortheymayarisefromanunknowncause.Thetreatmentvarieswidelydependingonthe type of tumor.To select the appropriate treatment,the surgeon must begin with anaccurate diagnosis.Theultimategoalsoftreatmentaretoeliminatethetumorandrestorethepatient’s long-termmobilityandfunction.
According to the most recent World Health Organization definitions, soft tissue tumors should be described as benign, intermediate (locally aggressive), intermediate (rarely metastasizing),andmalignant.Thesetermshavebeenintroducedtoeliminateconfusionarising fromoutdateddescriptionssuchas“intermediatemalignancy.”Accordingtothisterminology, benigntumorsgrowlocally,donotinfiltrate,donotrecur,orrecurinanondestructivefashion. Schwannomaisanexampleofa benigntumor.Intermediate(locallyaggressive)tumorsmay grow inan infiltrative fashionand may recur locallyunless excised with a wide marginof normal tissue. Plantar fibromais anexample.Intermediate (rarelymetastasizing)tumors are locallyaggressive,growinaninfiltrativefashion,andarelikelytorecurlocally,andalsohave a demonstrated ability to metastasize to distant sites. An example of this type of tumor is angiomatoidfibroushistiocytoma.Malignanttumorssuchassynovialsarcoma(SS)andclear cell sarcoma (CCS)grow inan aggressive, infiltrative, andlocallydestructive manner,and carryahighriskofregionalanddistantmetastasis.
The mostcommonbenign soft tissuetumors inthe footand ankle includeganglion cyst, plantar fibroma, hemangioma, schwannoma, neurofibroma, pigmented villonodular synovitis (PVNS),andgiantcelltumor oftendon sheath. Lipomaisrare inthe footandankle. Tumor mimicsarebenignnon-neoplasticsofttissuemasseswhosebehaviorissimilartothatoftrue tumors. Examples include gouty tophi, synovial cysts, synovial masses from degenerative
tendinopathy,rheumatoidnodules,andepidermalcysts.1Morethan100othertypesofbenign
https://t.me/medicina_free
andmalignantsofttissuetumorsmayoccurinthefoot,butacomprehensivedescriptionofthem is outside the scope of this chapter. Instead, a strategy for evaluation and management is presentedthatappliestoanytumor.
Alargerproportionofsofttissuetumorsinthefootandanklearemalignantthanelsewhere inthe body. Each individual surgeon’s chance of encountering a malignanttumor will vary dependingonpracticeprofileandreferralsources.Insomepublishedreports,asmanyas20% to62%ofsofttissuetumorsinthefootandanklearemalignant,althoughthetrueincidenceis
notknown.
1–3
Allfootandanklesurgeonsshouldbevigilant.Theriskofmalignancyincreases with age. Malignant melanoma is the most common soft tissue malignancy in the foot. Pleomorphicsarcoma(PS;previouslynamedmalignantfibroushistiocytoma[MFH]),SS,and CCSarethemostcommonsofttissuesarcomasinthefootandankle.
Surgeryistheprimaryformoflocalcontrolforfootandanklesarcomas.Thesurgeonmust achieve an appropriate margin around the tumor to minimize the risk of local recurrence. Surgicalmarginsaredefinedbythetermsintralesional,marginal,wide,andradical.Theterm enbloc,meaningthetumorisremovedinonepiece,hasnooncologicsignificanceandisnot by itself an adequate description. Opening, entering, or spilling the tumor by design or by accidentsuchasduring acurettageofabonecystalwayscreatesanintralesionalmargin.A marginalmarginiscreatedwhenthesurgeondissectsoutsidethetumoradjacenttothecapsule or pseudocapsule, even ifthe tumoris never entered or exposed.A wide marginis created whenthesurgeondissectscompletelyoutsidethepseudocapsuleandallreactiveorabnormal appearingtissues.Bydefinition,awidemarginincludesacontinuousunbrokencuffofnormal tissuesurroundingtheentiresurgicalspecimen.Aradicalmarginisachievedwhentheentire compartmentorcompartmentscontainingthetumorareresected,alongwithanyandallbone, nerve,vessel,ortendoninthecompartment.Toachievearadicalmargininthefootandankle atleastapartialamputationisrequired.
Forbenigntumors,simpleremovalwithanintralesionalorwidemarginisadequate.There isnoadverseeffectifthesurgeonspillstumorcellsintothenearbytissues,orleavesaportion of the tumor behind. For intermediate tumors, the risk of local recurrence and the debility associatedwithmultiplesurgeriesdemandsamorethoroughsurgicalapproach.Awidemargin is the goal, buta marginal marginis the most likely outcome. The surgical resection must encompasstheentiretumor,anypseudocapsule,andthethickestpossiblecuffofnormaltissue aroundthemass.Thesurgeoncanadjustthesizeofthemarginsaccordingtothepropensityof thetumortorecur.Forexample,plantarfibromaisabenigntumor,butitcarriesaveryhigh riskoflocalrecurrence,andamarginof1to2cmisoptimal.Aschwannomacanberesected withamarginalmargin.
Local control of malignant tumors requires an uncompromised wide margin. Wide resectionsaremorelikelytocompromisetheskeletalstability,neurovascularstatus,andsoft tissueintegrityofthelimb.Surgeonsseektobalanceandoptimizetheoncologicandfunctional
outcomes, andmayacceptmarginal marginsinordertofacilitatelimb salvage.4Thegoal of surgeryistoresecttheentiretumorenbloc,withanuncontaminatedmarginof5to10mmof normaltissuesurroundingallaspectsofthemass.Atruewidemarginrequiresthatnopartof thetumor,itscapsule,orthereactivezonearoundthetumoriseverseeninthesurgicalfield. Allpartsofthedissectiontakeplacethroughuninvolved,nonreactivenormaltissues,andthese
https://t.me/medicina_free
Table11-1.
normaltissuescompletelyenvelopallpartsoftheexcisedspecimen.Spillingorexposureof anypartoftheactualtumorisunacceptable.Surgeonswhoareunprepared forthedegreeof collateraldamagetothefootthatisrequiredtoachieveatruewidemarginaroundasarcoma shouldnotattempttheseresections.
Adjuvant chemotherapy and radiation therapy are given routinely for osteosarcoma and Ewingsarcoma,andareusedforotherhigh-gradesarcomasonacase-by-casebasis.Thereis strongevidencethatconservativesurgerycombinedwithradiationtherapyresultineffective local control. Postoperative radiationcan be administered by external beaminfractionated dosesorbybrachytherapyusingsurgicallyimplantedradiationsourceswithashorterduration oftreatment.Nostrongevidencefavorsonemethodovertheother.Thereisincreasinginterest inpreoperative radiationtherapy, whichmore precisely targets the tumor anddamagesless
normal tissue. However, a definite survival benefit has not yet been demonstrated.
5
Preoperativeradiationresultsinhigherratesofmajorwoundcomplications,whichmayhave devastatingeffectsinthefootandankle.
EVALUATIONOFASOFTTISSUEMASS
HistoryandPhysical
The initial evaluation should include a complete history, a comprehensive regional examination,andplainradiographsoftheaffectedarea.Thisinformationisthenusedbythe clinicianto determinethe likelihoodofmalignancy, todecide onthe besttypeof advanced imagingtoemploy, andtoevaluatetheneedforadiagnostic biopsy. For softtissuetumors, history and physical examination findings can be used to determine the potential for malignancy, based on the presence or absence of five specific “good” or “bad” clinical findings. This assessment is made based solely on the clinical features of the tumor; no advancedimagingisnecessary.Factorsincludedintheassessmentincludepain,growth,size, location,andexaminationfindings(Table11-1).Benigntumorsaremorelikelytobepainful, notprogressivelygrowing,small,superficialtothefascia,anddifficulttopalpateasadistinct mass.Malignanttumorstendtobepainless,progressivelygrowing,large,deeptothefascia, andwelldefinedonexam.Theriskofmalignancyincreaseswiththenumberof“bad”features thetumorhas.
ClinicalFeaturesThatHelpDistinguishBenignSoftTissue MassesfromMalignantSoftTissueTumors
Good Bad
Painhistory Painwaspresentfromthebeginning Nopainorpaindevelopedlater
Growthhistory Growsandshrinks Growsprogressively
Size Small(<2cm) Large(>3cm)
Location Superficial Deep
Findingsonexam Anindistinctmass Adefinitemass
https://t.me/medicina_free
Thelikelihoodofmalignancyincreasesasthenumberof“badfeatures”increases.
6
Certain physical examination findings might point toward a specific diagnosis. For example, hemangiomas have a characteristic blue-purple color that may be visible in the overlying skin. These lesions are typically painful to palpation. Ganglion cysts can be transilluminatedwithapenlightoralaserpointerand,whentransilluminationisdemonstrated, aspiratedtoconfirmthediagnosis.
Laboratorytestsarenotgenerallyusefulintheinitialmanagementoftumorsofthefootand ankle, unless there is clinical evidence of infection, an inflammatory condition such as rheumatoidarthritis,orgout.Nonspecificlaboratoryscreeningtestsarenotrecommended.
ImagingEvaluationofSoftTissueTumors
The history and physical examination may be adequate to confirm the diagnosis of many commonsofttissuemassesinthefootandankle,suchasganglioncystandplantarfibroma.In thesecases,imagingofthelesionmaynotbeclinicallyindicated.Forsofttissuetumorsthat cannotbereadilydiagnosed,twoorthogonalhigh-qualityplainradiographsarerecommended astheinitialimagingstudy.Theradiographicfindingsmaypointtoapossiblediagnosis.For example, intramuscular hemangiomas (IMHs) may contain small rounded pebble-like calcificationscalledphleboliths,whereas30%ofSSscontainamorphouscalcifications.Soft tissuesarcomasandmetastaticcancersinthefootmayinvadeanearbybone,aworrisomesign associatedwith malignancy. Advanced imaging otherthanMRI,suchas CTscans,positron emissiontomography(PET)scans,andbonescans,isnotcommonlyusefulintheevaluationof
softtissuelesions.
7
The malignant potential of some soft tissue tumors may be difficult to determine with confidence. The history and physical examination findings can be unhelpful or even misleading. A contrast-enhanced MRI examination with a dedicated extremity coil is recommendedforlesionslargerthan2or3cmandforallsofttissuetumorswithworrisome clinicalfeatures.TheMRIsignalcharacteristicsmayinsomecasesbeadequatetoidentifythe exactnatureofthe lesion,or forthe differentialtobe narrowed, butinothercases theMRI findingsarenonspecific.Nevertheless,MRIisveryhelpfulindeterminingthesizeandextent ofthetumoraswellasitsrelationshiptotheneurovascularelements.MRIisanessentialtool forclinicalstaging,biopsyplacement,surgicalplanning,andevaluationofresponsetotherapy.
DeterminateversusIndeterminateSoftTissueTumors
Asystematicapproachtoassessmentofthepotentialformalignancyofsofttissuemasseshas beenproposed wherebysoft tissuetumors are divided into two groups: “determinate” and “indeterminate”basedontheclinicalandradiographicfindings.Thesubsequentmanagement
planfollowsdirectlyfromthisassessment.
8,9
Softtissuetumorsforwhichaspecificdiagnosiscanbemadebasedonacombinationof history, the physical examination, and analysis of the MRI findings are called determinate lesions.Determinatelesionsthatmayoccurinthefootandankleincludelipoma,hemangioma, ganglion cyst, some plantar fibromas, and PVNS. Determinate lesions are treated with observationorbyexcisionalbiopsy,dependingontheclinicalsituation.
https://t.me/medicina_free
Soft tissuetumors forwhichnospecific diagnosis isconfirmedbythe exam,X-ray, and MRI findings are called indeterminate lesions. These lesions are typically isointense with muscle(dark)onT1-weightedimagingandhyperintense(bright)onT2-weightedimaging.In thefootandankle,thisgroupoftumorsincludesallsofttissuesarcomassuchasSS,CCS,and liposarcoma,aswellasanumberofbenigntumors,suchasgiantcelltumoroftendonsheath, peripheral nervesheath tumors,andsomeplantarfibromas.Indeterminatelesionsaretreated withincisionalorneedlebiopsy,alongwithappropriatereferraltoanorthopediconcologist. Ifthereisanydoubt,itisbesttodefer thebiopsytothespecialistteam.Definitivesurgical removalofindeterminatelesionsisalwaysperformedasaseparateprocedureafterthefinal pathologicdiagnosisandstagingarecompleted.
BIOPSYPLANNINGANDTECHNIQUES
Somefootandanklesurgeonsreferextremitytumorstoaspecialistforbiopsyanddefinitive treatment,whereasothersfeelcomfortablemanagingsofttissuelesionswithintheirscopeof practice. A systematic approachtothe performance ofthe biopsyis recommended because improper timing, technique, or management of the biopsy process increases the risk of complications.Thebiopsytechniqueshouldbechosenwithcaresothatanaccuratediagnosis ismadewithminimalrisk.Complicationsofimproperlyplannedorexecutedbiopsiesinclude errors in diagnosis, inadequate or nondiagnostic biopsy material, surgical site infection, hematoma, and contamination of nearby tissues. Biopsy complications have been shown to increase the riskofanotherwiseavoidableamputation.Theseproblems maybe avoided by earlyreferraltoanorthopediconcologistortumorspecialistpriortothebiopsy.
Thesurgeonisresponsibleforconsultingwiththepathologistpriortoperformingabiopsy incaseswheremalignancyispossible(forall indeterminatelesions). Directcommunication bytelephoneishighlyrecommended as a meansofinsuring thatthesurgeon andpathologist collaborateinanoptimalfashiontomaximizethediagnosticyieldofthebiopsyandminimize potentially devastating errors. Because the biopsywill alter theimaging appearance of the tumor,alldiagnosticscansshouldbecompletedpriortobiopsy.
Themostappropriatebiopsytechniqueshouldbeenselectedaccordingtotheclinicaland anatomic situation. Options include needle aspiration, tru-cut or large-bore needle biopsy, incisionalbiopsy,andexcisionalbiopsy.
Fineneedleaspiration(FNA)andcoreneedletechniqueshavetheadvantageofbeingwell tolerated by the patient and causing few complications. FNA is an appropriate choice for patientswithaknowncancerdiagnosiswhoaresuspectedtohavearecurrenceorametastasis inthefootorankle.FNAisalsousefulforotherlesionswherethereislittledoubtaboutthe diagnosisandthebiopsyisonlyneededtoconfirmwhatisalreadyknown.However,FNAis inadequatetoevaluatethetissuecytoarchitecture,andtheamountofmaterialobtainedmaybe inadequatefortissuebankingandancillarystudies.FNAandcoreneedlebiopsyisthefirst­line biopsy technique for soft tissue tumors in some cancer centers. In those centers, a dedicatedandexperiencedteammanagesallsofttissuetumors.Thisapproachcanminimizeor eliminatetheshortcomingsofneedletechniques.
In settings where an experienced biopsy team and an experienced solid tumor
https://t.me/medicina_free
Table11-2.
■
■
■
■
■
cytopathologist are not available, needle biopsy may be inadequate or inconclusive. Open (incisional)biopsytechniquesarepreferredinthesecases.Openbiopsyisasafeandeffective techniquewhenproperlyplannedandexecuted.Moretissueallowsforbetterunderstandingof the cytoarchitecture of the lesion and reduces the risk of a nondiagnostic result. Essential materialforancillarystudiesandtissuebankingcanbeobtained.
Excision of the tumor immediately after open biopsy is possible for a small group of tumors where the frozen section features of the tumor are highly diagnostic. This group includes giant cell tumor of tendon sheath, plantar fibroma, schwannoma, andother tumors dependingon theexperienceand confidenceofthe pathologist.Thesurgeonandpathologist should both be highly experienced in managing tumors. If sufficient doubt about the final diagnosis exists or the pathologist is not comfortable making a decision based on frozen sectionalone,thedefinitivesurgeryshouldbedelayeduntilthefinalpathologicanalysishas beencompleted.Mostindeterminatetumorswillrequireimmunohistochemicalstainsandother specializedexaminationsfordiagnosis.Definitivesurgerycantakeplace7to14daysafterthe biopsy.
Thesuccessofanincisionalbiopsydependsoncarefulprebiopsyplanning,properbiopsy execution,andadequatepostbiopsycareofthepatient(Table11-2).Allimagingstudiesmust becompletedpriortobiopsy.Thepathologistandthesurgeonshoulddiscussthecasepriorto thebiopsyortheymaydosointheoperatingroom.Atourniquetisappliedafterelevationbut without exsanguination. Tumor sampling is accomplished through adequate longitudinal incisionsthatapproachthelesionmostdirectly.Theincisionshouldbelongenoughtoallow visualizationoftheprocedure, confirmationof appropriate sampling,and hemostasis. Small “keyhole”biopsyincisionsarenotrecommended.Contaminationofuninvolvedstructuresand the neurovascularbundlesespeciallynearthemedialmalleolusshouldbecarefullyavoided. Thetourniquetshouldbereleasedafterthetumorissampled,andmeasuresshouldbetakento insurethatthewoundiscompletelydry.Unintentionalspreadofthetumormayoccurbecause of postbiopsy bleeding. A hematoma may track under subcutaneous tissues or through intramuscular spaces, causing a wide zone of contamination. During open biopsy, the pathologistshouldexamineafrozensectionofthebiopsymaterial toverifythatan adequate amountofviabletumorhasbeenobtained.Culturesshouldbeperformedunlessthepotential forinfectionhas been definitivelyruled out.A moderately compressive dressingshouldbe appliedandthepatientismadenonweight-bearingwiththeextremityelevatedfor3or4days. Thesurgeonwhoperformsthebiopsyshouldscheduleaface-to-faceencounterwiththepatient in7to10daystodiscusstheresultsoftheprocedureandthefuturetreatmentplan.Itisbestto avoiddeliveringbiopsyresultsoverthetelephoneorviaanintermediary.
ChecklistofTasksRequiredforaSuccessfulBiopsy
Prebiopsy
Allimagingstudiescompleted Appropriatebiopsytechniqueselected Imagingreviewedtoplanapproachandtumorsamplingstrategy Pathologistconsultedbytelephoneordirectlyinoperatingroom Operatingroomawareofafrozensectionplanned
https://t.me/medicina_free